| 121.90 Real-Time Quote |  +0.74 / +0.61%Today’s Change | 98.79 Today|||52-Week Range 121.99 | +17.18% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP -- |
Company Description
The Perrigo Co. manufactures, distributes and markets pharmaceutical and nutritional products. It offers over the counter, generic prescription pharmaceuticals, nutritional products, infant formulas, active pharmaceutical ingredients and medical diagnostic products. The company operates through four reportable segments: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals and Active Pharmaceutical Ingredients. The Consumer Healthcare segment includes the sale of over the counter pharmaceutical, nutritional products and infant formulas. The Nutritionals segment manufactures, markets and distributes store brand infant formula products, infant and toddler foods, vitamin, mineral and dietary supplement products and oral electrolyte solution products. The Rx Pharmaceuticals segment develops, manufactures creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquid suspensions and solutions. The Active Pharmaceutical Ingredients segment identifies active pharmaceutical ingredients that will be critical to its pharmaceutical customers future product launches and development processes. The company was founded in 1887 and is headquartered in Allegan, MI.
Employees
Shareholders
| Individual stakeholders | 7.13% |
| Mutual fund holders | 42.61% |
| Other institutional | 35.47% |
Top Executives
| Joseph C. Papa, MBA | Chairman, President & Chief Executive Officer |
| John T. Hendrickson | Executive VP-Global Operations & Supply Chain |
| Judy L. Brown, MBA, CPA | Chief Financial Officer & Executive Vice President |
| Thomas M. Farrington | Chief Information Officer & Senior Vice President |
| Jatin Shah, PhD | Chief Scientific Officer & Senior Vice President |
.
